MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$2,589K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Change in fair value of common s...
Change in fair value of derivati...
Others
Negative Cash Flow Breakdown
Net loss
Accrued liabilities
Operating lease obligations
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-13,424
-8,091
-9,226
-8,777
Depreciation
353
355
360
365
Non-cash lease expense
164
157
153
148
Issuance costs for common stock warrant liabilities
0
393
0
-
Loss on initial issuance of equity
0
-4,582
0
-
Issuance of common stock as payment of outstanding indebtedness
0
-
0
0
Change in fair value of common stock warrant liabilities
4,132
1,060
789
1,728
Change in fair value of derivative liabilities
-3,333
713
-274
-797
Change in fair value of clene nanomedicine contingent earn-out liability
-
-
0
0
Change in fair value of initial stockholders contingent earn-out liability
-
-
0
0
Stock-based compensation expense
1,040
1,312
1,365
1,703
Loss on extinguishment of notes payable
-
-
0
-
Loss on disposal of property and equipment
-
-
0
-
Accretion of debt discount
222
303
287
252
Non-cash interest income on marketable securities
-
-
0
0
Non-cash interest expense on notes payable
-388
-378
-372
-216
Accounts receivable
43
0
0
0
Inventory
-17
17
-24
-18
Prepaid expenses and other current assets
-1,867
3,279
-936
66
Accounts payable
-167
417
-477
541
Accrued liabilities
-247
-1,170
553
-465
Operating lease obligations
-223
-215
-209
-452
Net cash used in operating activities
-2,588
-4,528
-4,799
-3,992
Purchases of marketable securities
-
-
0
0
Proceeds from maturities of marketable securities
-
-
0
0
Purchases of property and equipment
1
-
28
11
Net cash used in investing activities
-1
0
-28
-11
Proceeds from exercise of stock options
-
-
0
0
Proceeds from issuance of common stock, net of offering costs
-
-
-
3,266
Proceeds from share subscriptions payable
-
-
-
0
Proceeds from issuance of common stock and warrants, net of offering costs
6,421
5,324
10,402
-
Proceeds from the issuance of debt and derivative liabilities
-
-
0
1,500
Payments of notes payable
92
90
89
124
Payments of finance lease obligations
-
-
0
0
Net cash provided by financing activities
6,329
5,234
2,070
4,642
Effect of foreign exchange rate changes on cash and restricted cash
-8
44
21
1
Net increase (decrease) in cash, cash equivalents and restricted cash
3,732
750
-2,736
640
Cash, cash equivalents and restricted cash beginning of period
5,997
5,247
7,983
12,213
Cash, cash equivalents and restricted cash end of period
9,729
5,997
5,247
7,983
Cash and cash equivalents
9,671
-
-
-
Restricted cash
58
-
-
-
Cash, cash equivalents and restricted cash
9,729
-
-
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common stock and...
$6,421K
Net cash provided by
financing activities
$6,329K
(31.69%↑ Y/Y)
Canceled cashflow
$92K
Net increase
(decrease) in cash, cash...
$3,732K
(176.63%↑ Y/Y)
Canceled cashflow
$2,597K
Payments of notes payable
$92K
(-46.20%↓ Y/Y)
Change in fair value of
common stock warrant...
$4,132K
(307.12%↑ Y/Y)
Change in fair value of
derivative liabilities
-$3,333K
(-570.76%↓ Y/Y)
Prepaid expenses and
other current assets
-$1,867K
(-348.60%↓ Y/Y)
Stock-based compensation
expense
$1,040K
(-68.62%↓ Y/Y)
Non-cash interest
expense on notes payable
-$388K
(-1516.67%↓ Y/Y)
Depreciation
$353K
(-54.16%↓ Y/Y)
Accretion of debt discount
$222K
(-54.51%↓ Y/Y)
Non-cash lease expense
$164K
(-39.26%↓ Y/Y)
Inventory
-$17K
(-254.55%↓ Y/Y)
Net cash used in
operating activities
-$2,588K
(73.47%↑ Y/Y)
Effect of foreign
exchange rate changes on...
-$8K
(-110.13%↓ Y/Y)
Net cash used in
investing activities
-$1K
Canceled cashflow
$11,516K
Net loss
-$13,424K
(-64.31%↓ Y/Y)
Purchases of property and
equipment
$1K
Accrued liabilities
-$247K
(89.29%↑ Y/Y)
Operating lease
obligations
-$223K
(34.22%↑ Y/Y)
Accounts payable
-$167K
(59.47%↑ Y/Y)
Accounts receivable
$43K
(167.19%↑ Y/Y)
Buy us a coffee
Clene Inc. (CLNN)
Clene Inc. (CLNN)